SSX3 Antilichaam - middengebied: FITC (ARP51078 P050-FITC)

CT5.3

10214

Q99909

Human

The immunogen is a synthetic peptide directed towards the middle region of Human SSX3

The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneous humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. While some of the related SSX genes are involved in t (X;18) (p11.2; q11.2) translocations that are characteristically found in all synovial sarcomas, this gene does not appear to be involved in such translocations.

MIPOL1; SSX2IP; CMTM5; CEP70; CEP63; RHOJ; AGTRAP; MED4; MEOX2; ZSCAN1; ZNF496; PCBD2; ZBTB3; ZBTB25; DDIT3

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

0.5 mg/ml

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

20kDa

Wet Ice

188

SSX3

SSX3

Rabbit

FGRLQGIFPKIMPKKPAEEGNVSKEVPEASGPQNDGKQLCPPGKPTTSEK